Section Arrow
Quote
ZTS.NYSE
- ZOETIS
Quotes are at least 15-min delayed:2025/02/23 10:11 EST
Last
 160.46
+3.04 (+1.93%)
Day High 
160.91 
Prev. Close
157.42 
1-M High
177.4 
Volume 
3.30M 
Bid
160
Ask
162.6
Day Low
157.6 
Open
157.78 
1-M Low
154.32 
Market Cap 
70.49B 
Currency USD 
P/E 28.78 
%Yield 1.12 
10-SMA 165.86 
20-SMA 168.57 
50-SMA 168.28 
52-W High 200.5341 
52-W Low 144.8 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
5.47/6.83
Enterprise Value
75.89B
Balance Sheet
Book Value Per Share
10.65
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
9.26B
Operating Revenue Per Share
18.69
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 10:11 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.